Sardor Koriyev, Director of the Agency for Development of the Pharmaceutical Industry, met with a delegation from Russia.

According to the Agency, issues of establishing mutually beneficial cooperation within the framework of innovative research and production cluster Tashkent Pharma Park were discussed at a meeting with the Advisor to the First Vice President of JSC Gazprombank, Head of the Competence Center for Digital Transformation of the Healthcare Sector of the Ministry of Health of the Russian Federation, Vice President of IBA, a manufacturer of advanced medical equipment in proton therapy.

During the talks, issues of localization of the production of innovative pharmaceuticals, the establishment of the production of radiopharmaceuticals and the creation of an integrated electronic system for a clinical research center and a medical hospital were considered.

UzA